BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 29540160)

  • 1. Effect of Lactobacillus rhamnosus HN001 on carriage of Staphylococcus aureus: results of the impact of probiotics for reducing infections in veterans (IMPROVE) study.
    Eggers S; Barker AK; Valentine S; Hess T; Duster M; Safdar N
    BMC Infect Dis; 2018 Mar; 18(1):129. PubMed ID: 29540160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Probiotics for Reducing Infections in Veterans (IMPROVE): Study protocol for a double-blind, randomized controlled trial to reduce carriage of Staphylococcus aureus.
    Eggers S; Barker A; Valentine S; Hess T; Duster M; Safdar N
    Contemp Clin Trials; 2017 Jan; 52():39-45. PubMed ID: 27836508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerability of a probiotic in subjects with a history of methicillin-resistant Staphylococcus aureus colonisation.
    Warrack S; Panjikar P; Duster M; Safdar N
    Benef Microbes; 2014 Dec; 5(4):389-95. PubMed ID: 25213147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Toxic Shock Syndrome-Associated
    Schlievert PM; Gaitán AV; Kilgore SH; Roe AL; Maukonen J; Lehtoranta L; Leung DYM; Marsman DS
    Microbiol Spectr; 2023 Aug; 11(4):e0173523. PubMed ID: 37404182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotic cheese containing Lactobacillus rhamnosus HN001 and Lactobacillus acidophilus NCFM® modifies subpopulations of fecal lactobacilli and Clostridium difficile in the elderly.
    Lahtinen SJ; Forssten S; Aakko J; Granlund L; Rautonen N; Salminen S; Viitanen M; Ouwehand AC
    Age (Dordr); 2012 Feb; 34(1):133-43. PubMed ID: 21264685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early pregnancy probiotic supplementation with Lactobacillus rhamnosus HN001 may reduce the prevalence of gestational diabetes mellitus: a randomised controlled trial.
    Wickens KL; Barthow CA; Murphy R; Abels PR; Maude RM; Stone PR; Mitchell EA; Stanley TV; Purdie GL; Kang JM; Hood FE; Rowden JL; Barnes PK; Fitzharris PF; Crane J
    Br J Nutr; 2017 Mar; 117(6):804-813. PubMed ID: 28367765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eczema-protective probiotic alters infant gut microbiome functional capacity but not composition: sub-sample analysis from a RCT.
    Murphy R; Morgan XC; Wang XY; Wickens K; Purdie G; Fitzharris P; Otal A; Lawley B; Stanley T; Barthow C; Crane J; Mitchell EA; Tannock GW
    Benef Microbes; 2019 Feb; 10(1):5-17. PubMed ID: 30574802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival of Lactobacillus reuteri DSM 17938 and Lactobacillus rhamnosus GG in the human gastrointestinal tract with daily consumption of a low-fat probiotic spread.
    Dommels YE; Kemperman RA; Zebregs YE; Draaisma RB; Jol A; Wolvers DA; Vaughan EE; Albers R
    Appl Environ Microbiol; 2009 Oct; 75(19):6198-204. PubMed ID: 19684171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early supplementation with Lactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitization?
    Wickens K; Stanley TV; Mitchell EA; Barthow C; Fitzharris P; Purdie G; Siebers R; Black PN; Crane J
    Clin Exp Allergy; 2013 Sep; 43(9):1048-57. PubMed ID: 23957340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of
    Toscano M; De Grandi R; Stronati L; De Vecchi E; Drago L
    World J Gastroenterol; 2017 Apr; 23(15):2696-2704. PubMed ID: 28487606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of probiotics in the prevention and treatment of meticillin-resistant Staphylococcus aureus infections.
    Sikorska H; Smoragiewicz W
    Int J Antimicrob Agents; 2013 Dec; 42(6):475-81. PubMed ID: 24071026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Lactobacillus rhamnosus HN001 in Pregnancy on Postpartum Symptoms of Depression and Anxiety: A Randomised Double-blind Placebo-controlled Trial.
    Slykerman RF; Hood F; Wickens K; Thompson JMD; Barthow C; Murphy R; Kang J; Rowden J; Stone P; Crane J; Stanley T; Abels P; Purdie G; Maude R; Mitchell EA;
    EBioMedicine; 2017 Oct; 24():159-165. PubMed ID: 28943228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and molecular characterization of
    Kates AE; Thapaliya D; Smith TC; Chorazy ML
    Antimicrob Resist Infect Control; 2018; 7():42. PubMed ID: 29568515
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Spacova I; O'Neill C; Lebeer S
    Benef Microbes; 2020 Nov; 11(7):703-715. PubMed ID: 33084369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Lactobacillus rhamnosus GG Administration on Vancomycin-Resistant Enterococcus Colonization in Adults with Comorbidities.
    Doron S; Hibberd PL; Goldin B; Thorpe C; McDermott L; Snydman DR
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4593-9. PubMed ID: 26014940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the kinetics of intestinal colonization by associating 5 probiotic bacteria assumed either in a microencapsulated or in a traditional, uncoated form.
    Piano MD; Carmagnola S; Ballarè M; Balzarini M; Montino F; Pagliarulo M; Anderloni A; Orsello M; Tari R; Sforza F; Mogna L; Mogna G
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S85-92. PubMed ID: 22955366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of a multi-strain probiotic on the resistance toward Escherichia coli challenge in a randomized, placebo-controlled, double-blind intervention study.
    Ten Bruggencate SJ; Girard SA; Floris-Vollenbroek EG; Bhardwaj R; Tompkins TA
    Eur J Clin Nutr; 2015 Mar; 69(3):385-91. PubMed ID: 25369827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro Anti-staphylococcal and Anti-inflammatory Abilities of Lacticaseibacillus rhamnosus from Infant Gut Microbiota as Potential Probiotic Against Infectious Women Mastitis.
    Bousmaha-Marroki L; Boutillier D; Marroki A; Grangette C
    Probiotics Antimicrob Proteins; 2021 Aug; 13(4):970-981. PubMed ID: 33649898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence, risk factors and sequelae of Staphylococcus aureus carriage in diabetes: the Fremantle Diabetes Study Phase II.
    Hart J; Hamilton EJ; Makepeace A; Davis WA; Latkovic E; Lim EM; Dyer JR; Davis TM
    J Diabetes Complications; 2015; 29(8):1092-7. PubMed ID: 26243688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of and risk factors for nasal methicillin-resistant Staphylococcus aureus colonization among children in central Taiwan.
    Pan HH; Huang YC; Chen CJ; Huang FL; Ting PJ; Huang JY; Chiu CH; Lin TY; Chen PY
    J Microbiol Immunol Infect; 2019 Feb; 52(1):45-53. PubMed ID: 29615348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.